PEI Group’s latest GP-led Secondaries report uncovers what comes next for this burgeoning corner of the market.
From CVs on CVs to greater specialisation, secondaries professionals who have previously featured on our rising stars list share their insights on the market’s evolution.
As the secondaries market braces itself for the next round of macroeconomic uncertainty, there is a playbook based on previous choppy markets.
From increased LP selling to a new normal for CVs, here are some of the events that attendees at PEI Group’s NEXUS 2026 conference expect to see in the secondaries market this year.
We’ll hear the latest on the market’s innovation, capitalisation, tailwinds and headwinds at PEI Group’s Nexus 2026.
Pricing on VC secondaries is less attractive now, says Schroders Capital venture chief Steven Yang.
Will we finally see a wave of IPOs this year, or will VC GPs have to turn to the secondaries market to deliver liquidity to their investors?
Holding on to laggard assets may conflict with the core objective of PE: maximising time-weighted returns for LPs, writes Adam Spence, of Partners Capital.
Pressures in private equity continued in 2025, with fundraising dipping by 17% year on year in 2025.
Sovereign funds and insurers are using third-time-round fund stake transactions as part of their portfolio management processes, write Caspar Berendsen, Álvaro Rosado and Robert Perry.